Colony-forming assay for circulating chronic lymphocytic leukemia cells

Area of Science:

• Hematology
• Cancer Biology
• Cell Biology

Background:

• Chronic lymphocytic leukemia (CLL) is a B-cell malignancy.
• Understanding CLL cell proliferation and drug sensitivity is crucial for treatment.
• Existing assays may not fully capture CLL cell behavior.

Purpose of the Study:

• To adapt a colony-forming assay for chronic lymphocytic leukemia (CLL) peripheral blood cells.
• To characterize the proliferation and drug sensitivity of CLL cells using this assay.
• To explore the potential clinical utility of the assay in predicting treatment response.

Main Methods:

• Culturing T-lymphocyte-depleted CLL cells with normal T cells and conditioned media in methylcellulose.
• Assessing colony formation, cell cycle phase (thymidine suicide), and surface markers.
• Evaluating in vitro response of CLL colony-forming cells to adriamycin and melphalan.

Main Results:

• Colonies of small and transformed lymphocytes formed within 5-7 days with a plating efficiency of 0.15%.
• CLL colony-forming cells were predominantly in S phase, inversely related to white blood cell count.
• CLL cells in colonies expressed monoclonal immunoglobulin light chains, confirming B-cell origin.
• Preliminary data suggest differential melphalan sensitivity based on prior treatment history.

Conclusions:

• The adapted colony-forming assay effectively supports CLL cell growth and characterization.
• The assay provides insights into CLL cell proliferation kinetics and cell cycle status.
• This system offers a valuable tool for investigating CLL biology and predicting chemotherapy response.